D
Dr. Prashant Kumar
Karkinos Healthcare, Somaiya Vidyavihar University, Max Planck Institute for Infection Biology, University of Allahabad, Institute of Bioinformatics
0000-0001-8975-5108
Employment
-
Karkinos Healthcare Chief Scientific Officer & Research Director2022 - Present
-
Somaiya Vidyavihar University Dean of Research & Director SIRAC2021 - 2022
-
Institute of Bioinformatics Faculty Scientist2015 - 2021
Education
-
Max Planck Institute for Infection Biology Ph.D. in Molecular Biology2005 - 2009
-
University of Allahabad M.Sc. in Biotechnology1999 - 2002
Projects & Funding
Projects & funding information is unavailable.
Publications (58)
- Addendum: Liquid biopsy and multi-analyte testing guided treatment of HER2 positive periampullary adenocarcinoma with durable complete response after trastuzumab based therapy. Save
- Drug susceptibility testing of circulating lung cancer cells for personalized treatment. Save
- Integrated proteomics and phosphoproteomics revealed druggable kinases in neoadjuvant chemotherapy resistant tongue cancer. Save
- Sustained response on sequential anti-FGFR therapy in metastatic gall bladder cancer: a case report and literature review. Save
- Snail maintains the stem/progenitor state of skin epithelial cells and carcinomas through the autocrine effect of matricellular protein Mindin. Save
- Addendum: A case report of androgen receptor inhibitor therapy in recurrent high-grade serous ovarian cancer. Save
- Pan-cancer quantitation of epithelial-mesenchymal transition dynamics using parallel reaction monitoring-based targeted proteomics approach. Save
- Insights into therapy resistance in cervical cancer Save
- Angiogenesis Inhibitors in Personalized Combination Regimens for the Treatment of Advanced Refractory Cancers Save
- Integrated Proteomic and Phosphoproteomics Analysis of DKK3 Signaling Reveals Activated Kinase in the Most Aggressive Gallbladder Cancer Save